AI Analysis AI Analysis of BEAM AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add BEAM to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Red day on Friday for Beam Therapeutics Inc. stock after losing 3.03%
(Updated on Jul 17, 2026)

SIGN UP FREE
or
Creating an account or logging in means you agree to StockInvest.us Terms of Use and Privacy Policy.
Sell candidate since Jul 13, 2026 Loss -11.19%

The Beam Therapeutics Inc. stock price fell by -3.03% on the last day (Friday, 17th Jul 2026) from $28.39 to $27.53. It has now fallen 8 days in a row. During the last trading day the stock fluctuated 5.20% from a day low at $27.10 to a day high of $28.51. The price has fallen in 8 of the last 10 days and is down by -20.87% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -2 million shares and in total, 2 million shares were bought and sold for approximately $52.66 million.

The stock has broken the very wide and strong rising short-term trend down. This signalizes a slower rate of rising, but may also be an early warning about a possible trend shift. Due to the trend being broken there will now be resistance at the bottom line of the trend at $28.89. A reaction back to this level may hold a second chance to get out before further falls.

BEAM Signals & Forecast

There are few to no technical positive signals at the moment. The Beam Therapeutics Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $31.02 and $32.31. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Tuesday, July 07, 2026, and so far it has fallen -27.40%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Sell
Special Signal Notification

Double Top Formation

Double Top Formation A sell signal from a double top formation was found on Thursday, June 04, 2026 and based on theory for this formation the price should fall by -8.57% to $25.17 within 4 trading days (Wednesday, June 10, 2026) since signal was issued.

Support, Risk & Stop-loss for Beam Therapeutics Inc. stock

Beam Therapeutics Inc. finds support from accumulated volume at $27.11 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $1.41 between high and low, or 5.20%. For the last week, the stock has had daily average volatility of 5.49%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (BEAM) For The Upcoming Trading Day Of Monday 20th

For the upcoming trading day on Monday, 20th we expect Beam Therapeutics Inc. to open at $27.71, and during the day (based on 14 day Average True Range), to move between $26.33 and $28.73, which gives a possible trading interval of +/-$2.40 (+/-9.10%) up or down from last closing price. If Beam Therapeutics Inc. takes out the full calculated possible swing range there will be an estimated 9.10% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $27.11 (1.53%) than the resistance at $28.39 (3.12%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Beam Therapeutics Inc. stock A Buy?

The Beam Therapeutics Inc. stock holds several negative signals and despite the positive trend, we believe Beam Therapeutics Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

Current score: -3.232 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on July 20, 2026 - $27.71 ( 0.666%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

BEAM Performance

Trading levels for BEAM

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 29.12 5.79%
R2 28.58 3.83%
R1 28.25 2.62%
Price 27.53
S1 27.17 -1.29%
S2 26.84 -2.50%
S3 26.30 -4.46%

Accumulated Volume Support & Resistance Levels

Level Price
R3 33.20 20.60%
R2 32.84 19.29%
R1 28.39 3.12%
Price 27.53
S1 27.11 -1.53%
S2 26.81 -2.62%
S3 26.33 -4.36%

BEAM Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Jan 22, 2014 Feb 04, 2014 Mar 03, 2014 $0.225 0%
2 Sep 19, 2013 Nov 04, 2013 Dec 02, 2013 $0.225 0%
3 Jul 31, 2013 Aug 12, 2013 Sep 03, 2013 $0.225 0%
4 Apr 24, 2013 May 06, 2013 Jun 03, 2013 $0.225 0%
5 Jan 28, 2013 Feb 04, 2013 Mar 01, 2013 $0.225 0%

FAQ

What is the symbol for Beam Therapeutics Inc. Stock and on which exchange is it traded?
The symbol for Beam Therapeutics Inc. is BEAM and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Beam Therapeutics Inc. Stock?
The Beam Therapeutics Inc. stock holds several negative signals and despite the positive trend, we believe Beam Therapeutics Inc. will perform weakly in the next couple of days or weeks. Therefore, we hold a negative evaluation of this stock.

How to buy Beam Therapeutics Inc. Stock?
Beam Therapeutics Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Beam Therapeutics Inc. Stock.

What's the current price of Beam Therapeutics Inc. Stock?
As of the end of day on the Jul 17, 2026, the price of an Beam Therapeutics Inc. (BEAM) share was $27.53.

What is the 52-week high and low for Beam Therapeutics Inc. Stock?
The 52-week high for Beam Therapeutics Inc. Stock is $38.26 and the 52-week low is $15.60.

What is the market capitalization of Beam Therapeutics Inc. Stock?
As of the Jul 17, 2026, the market capitalization of Beam Therapeutics Inc. is 2.832B.

When is the next earnings date for Beam Therapeutics Inc.?
The upcoming earnings date for Beam Therapeutics Inc. is Aug 04, 2026.
Click to get the best stock tips daily for free!
ABOUT BEAM THERAPEUTICS INC.
Beam Therapeutics
Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen receptor T cell for the treatment of relapsed/refractory T-cell acute lymphoblastic leukemia; and BEAM-...
GOLDEN STAR
Ticker Change Signal Date
DHT
$17.31
0.578% Jul 13
SRPT
$17.02
1.18% Jun 29
JLL
$299.78
10.30% Jun 24
NMRK
$15.02
3.86% Jun 24
CAG
$13.43
6.29% Jun 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE